International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases

被引:242
作者
Chow, E
Wu, JSY
Hoskin, P
Coia, LR
Bentzen, SM
Blitzer, PH
机构
[1] Univ Toronto, Dept Radiat Oncol, Toronto Sunnybrook Reg Canc Ctr, Toronto, ON M4N 3M5, Canada
[2] Tom Baker Canc Clin, Dept Radiat Oncol, Calgary, AB, Canada
[3] Mt Vernon Hosp, Mt Vernon Ctr Canc Treatment, Northwood HA6 2RN, Middx, England
[4] Community Med Ctr, Dept Radiat Oncol, Toms River, NJ USA
[5] Radiat Therapy Associates, Cape Coral, FL USA
[6] Mt Vernon Hosp, Gray Lab, Canc Res Trust, Northwood HA6 2RN, Middx, England
[7] Mt Vernon Hosp, Ctr Canc, Northwood HA6 2RN, Middx, England
关键词
international consensus; palliative radiotherapy endpoints; future clinical trials; bone metastases;
D O I
10.1016/S0167-8140(02)00170-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To reach a consensus on a set of optimal endpoint measurements for future external beam radiotherapy trials in bone metastases. Methods: An International Bone Metastases Consensus Working Party invited principal investigators and individuals with a recognized interest in bone metastases to participate in the two surveys and a panel meeting on their preference of choice of optimal endpoints. Results: Consensus has been reached on the following: (a) eligibility criteria for future trials; (b) pain and analgesic assessments; (c) radiation techniques; (d) follow-up and timing of assessments; (e) parameters at follow-up; (f) endpoints; (g) re-irradiation; and (h) statistical analysis. Conclusions: Based on the available literature and the clinical experience of the working party members, an acceptable set of endpoints has been agreed upon for future clinical trials to promote consistency in reporting. It is intended that the consensus will be re-examined every 5 years. Areas of further research were identified. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:275 / 280
页数:6
相关论文
共 40 条
[1]  
Ashton A, 1999, RADIOTHER ONCOL, V52, P111
[2]  
BEALS RK, 1971, CANCER, V28, P1350, DOI 10.1002/1097-0142(1971)28:5<1350::AID-CNCR2820280539>3.0.CO
[3]  
2-6
[4]   Fractionated radiotherapy for metastatic bone pain: Evidence-based medicine or ...? [J].
Bentzen, SM ;
Hoskin, P ;
Roos, D ;
Nielsen, OS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (03) :681-682
[5]  
BLITZER PH, 1985, CANCER-AM CANCER SOC, V55, P1468, DOI 10.1002/1097-0142(19850401)55:7<1468::AID-CNCR2820550708>3.0.CO
[6]  
2-M
[7]   Pain measurement tools and methods in clinical research in palliative care: Recommendations of an Expert Working Group of the European Association of Palliative Care [J].
Caraceni, A ;
Cherny, N ;
Fainsinger, R ;
Kaasa, S ;
Poulain, P ;
Radbruch, L ;
De Conno, F .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 23 (03) :239-255
[8]   How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review [J].
Chow, E ;
Harth, T ;
Hruby, G ;
Finkelstein, J ;
Wu, J ;
Danjoux, C .
CLINICAL ONCOLOGY, 2001, 13 (03) :209-218
[9]  
Cole D J, 1989, Clin Oncol (R Coll Radiol), V1, P59, DOI 10.1016/S0936-6555(89)80035-4
[10]   INCIDENCE OF FRACTURE THROUGH METASTASES IN LONG BONES [J].
FIDLER, M .
ACTA ORTHOPAEDICA SCANDINAVICA, 1981, 52 (06) :623-627